Close Menu

NEW YORK (GenomeWeb) – Illumina announced today that it has filed two patent infringements lawsuits against five companies in Europe over their use of noninvasive prenatal tests that Illumina claims violate its intellectual property protections.

Illumina filed suit in the UK against The Doctors Laboratory, TDL Genetics, and Ariosa Diagnostics, alleging that The Doctors Laboratory's and TDL Genetics' use of the Harmony NIPT tests supplied by Ariosa infringe on Illumina's European Patent 0 994 963.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.